bluebird bio Inc (BLUE)
0.9229
-0.05
(-4.91%)
USD |
NASDAQ |
Apr 24, 16:00
0.9231
0.00 (0.00%)
After-Hours: 05:42
bluebird bio Cash from Operations (Quarterly): -61.85M for Sept. 30, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -61.85M |
| June 30, 2023 | -72.72M |
| March 31, 2023 | -86.64M |
| December 31, 2022 | -56.27M |
| September 30, 2022 | -77.03M |
| June 30, 2022 | -94.36M |
| March 31, 2022 | -125.30M |
| December 31, 2021 | -139.72M |
| September 30, 2021 | -146.94M |
| June 30, 2021 | -145.65M |
| March 31, 2021 | -203.33M |
| December 31, 2020 | -155.19M |
| September 30, 2020 | -148.78M |
| June 30, 2020 | 39.74M |
| March 31, 2020 | -206.12M |
| December 31, 2019 | -158.98M |
| September 30, 2019 | -113.38M |
| June 30, 2019 | -137.87M |
| March 31, 2019 | -154.15M |
| December 31, 2018 | -129.73M |
| September 30, 2018 | -74.47M |
| June 30, 2018 | -100.40M |
| March 31, 2018 | -108.82M |
| December 31, 2017 | -95.38M |
| Date | Value |
|---|---|
| September 30, 2017 | -56.34M |
| June 30, 2017 | -53.53M |
| March 31, 2017 | -75.30M |
| December 31, 2016 | -69.11M |
| September 30, 2016 | -39.44M |
| June 30, 2016 | -44.33M |
| March 31, 2016 | -36.77M |
| December 31, 2015 | -33.08M |
| September 30, 2015 | -29.07M |
| June 30, 2015 | -12.12M |
| March 31, 2015 | -24.16M |
| December 31, 2014 | -15.66M |
| September 30, 2014 | -20.77M |
| June 30, 2014 | -11.32M |
| March 31, 2014 | -11.93M |
| December 31, 2013 | -5.455M |
| September 30, 2013 | -8.86M |
| June 30, 2013 | -8.253M |
| March 31, 2013 | 66.02M |
| December 31, 2012 | -6.636M |
| September 30, 2012 | -4.223M |
| June 30, 2012 | -3.985M |
| March 31, 2012 | -6.20M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-206.12M
Minimum
Mar 2020
39.74M
Maximum
Jun 2020
-116.13M
Average
-131.58M
Median
Cash from Operations (Quarterly) Benchmarks
| Novavax Inc | -176.78M |
| Motus GI Holdings Inc | -1.856M |
| Tivic Health Systems Inc | -1.774M |
| Vertex Pharmaceuticals Inc | 234.60M |
| AIM ImmunoTech Inc | -9.758M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 62.08M |
| Cash from Financing (Quarterly) | -0.042M |
| Free Cash Flow | -286.43M |
| Free Cash Flow Per Share (Quarterly) | -0.5856 |
| Free Cash Flow to Equity (Quarterly) | -63.88M |
| Free Cash Flow to Firm (Quarterly) | -63.88M |
| Free Cash Flow Yield | -305.5% |